Synergy Biomedical
Synergy: Enhancing bone healing with our optimal bioactive glass biomaterial products.
Founded
2011Synergy: Enhancing bone healing with our optimal bioactive glass biomaterial products.
Founded with a mission to revolutionize bone healing, Synergy Biomedical focuses on developing advanced biomaterial-based products. The company has pioneered the use of bioactive glass particles, specifically designed with a spherical shape and bimodal size range, to significantly enhance bone regeneration. Their product lineup includes BioSphere® PUTTY, BioSphere® MIS, BioSphere® Flex, and other specialized formulations aimed at improving surgical outcomes. Synergy targets healthcare professionals and distributors in the orthopedic and dental markets.
Synergy Biomedical has garnered attention for its innovative approach to biomaterials, attracting notable investors and partnerships within the medical device industry. The company's key achievements include the successful development and commercialization of their BioSphere® product line, which has been well-received by surgeons for its effectiveness in bone healing. Through its cutting-edge technology and commitment to quality, Synergy Biomedical has made a significant impact on patient care, setting new standards in the field of regenerative medicine.
Companies similar to Synergy Biomedical include Bone Biologics, Orthopaedic Synergy, RevBio and Biomimedica.
Synergy Biomedical was founded in 2011.
Synergy Biomedical's headquarters is located in Collegeville, PA, US.
Synergy Biomedical's most recent funding round was for $611.9k (USD) in March 2014.
As of Mar 5, 2014, Synergy Biomedical has disclosed funding of $1.2M (USD). Undisclosed round amounts are excluded.
Synergy Biomedical has 8 employees as of Feb 5, 2024.
biomimedica.com
